Free Trial

Equifax (NYSE:EFX) Price Target Lowered to $272.00 at JPMorgan Chase & Co.

Equifax logo with Business Services background

Equifax (NYSE:EFX - Get Free Report) had its price objective reduced by JPMorgan Chase & Co. from $277.00 to $272.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an "overweight" rating on the credit services provider's stock. JPMorgan Chase & Co.'s price objective indicates a potential upside of 10.48% from the company's previous close.

Several other research analysts also recently issued reports on the stock. Wells Fargo & Company lowered their price target on shares of Equifax from $310.00 to $300.00 and set an "overweight" rating for the company in a report on Wednesday. BMO Capital Markets started coverage on Equifax in a research report on Thursday, July 10th. They issued a "market perform" rating and a $280.00 target price for the company. Stifel Nicolaus boosted their price target on Equifax from $277.00 to $295.00 and gave the stock a "buy" rating in a report on Wednesday, June 18th. Oppenheimer upped their price objective on Equifax from $277.00 to $296.00 and gave the company an "outperform" rating in a research note on Thursday, May 22nd. Finally, Morgan Stanley reiterated an "overweight" rating and set a $305.00 target price (up from $295.00) on shares of Equifax in a research report on Tuesday, June 10th. Seven equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $285.00.

Read Our Latest Analysis on Equifax

Equifax Price Performance

Shares of Equifax stock traded up $0.33 during trading on Wednesday, reaching $246.19. 1,665,798 shares of the company's stock were exchanged, compared to its average volume of 1,032,500. The firm's 50-day moving average price is $261.94 and its 200 day moving average price is $253.09. The company has a market cap of $30.48 billion, a P/E ratio of 48.18, a PEG ratio of 2.82 and a beta of 1.60. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.85 and a current ratio of 0.77. Equifax has a 1-year low of $199.98 and a 1-year high of $309.63.

Equifax (NYSE:EFX - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The credit services provider reported $2.00 earnings per share for the quarter, beating analysts' consensus estimates of $1.92 by $0.08. The company had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.51 billion. Equifax had a net margin of 10.95% and a return on equity of 18.89%. The firm's quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the company posted $1.82 EPS. As a group, research analysts anticipate that Equifax will post 7.58 earnings per share for the current year.

Insider Activity

In other Equifax news, EVP John W. Gamble, Jr. sold 2,000 shares of Equifax stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $259.10, for a total value of $518,200.00. Following the completion of the sale, the executive vice president directly owned 65,176 shares in the company, valued at approximately $16,887,101.60. The trade was a 2.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Mark W. Begor sold 22,160 shares of the business's stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $256.61, for a total value of $5,686,477.60. Following the completion of the transaction, the chief executive officer directly owned 142,395 shares in the company, valued at approximately $36,539,980.95. This trade represents a 13.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.40% of the company's stock.

Institutional Trading of Equifax

Several large investors have recently modified their holdings of the stock. True Wealth Design LLC boosted its holdings in Equifax by 1,920.0% in the fourth quarter. True Wealth Design LLC now owns 101 shares of the credit services provider's stock worth $26,000 after acquiring an additional 96 shares in the last quarter. Ameriflex Group Inc. bought a new position in shares of Equifax in the fourth quarter valued at $28,000. N.E.W. Advisory Services LLC acquired a new position in shares of Equifax during the first quarter valued at about $28,000. Ameritas Advisory Services LLC acquired a new stake in shares of Equifax in the 2nd quarter worth about $31,000. Finally, Colonial Trust Co SC lifted its position in Equifax by 505.0% in the 4th quarter. Colonial Trust Co SC now owns 121 shares of the credit services provider's stock valued at $31,000 after acquiring an additional 101 shares in the last quarter. Institutional investors and hedge funds own 96.20% of the company's stock.

Equifax Company Profile

(Get Free Report)

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

See Also

Analyst Recommendations for Equifax (NYSE:EFX)

Should You Invest $1,000 in Equifax Right Now?

Before you consider Equifax, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.

While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines